Glob­al syn­di­cate backs $400M ge­nomics R&D play in Ire­land as WuXi NextCODE ex­tends its reach in­to Eu­rope

The big push to trans­late fresh mounds of ge­nomics da­ta in­to new meds got a sig­nif­i­cant boost to­day as an in­ter­na­tion­al syn­di­cate of in­vestors from the US, Chi­na, Ire­land and Sin­ga­pore backed Wuxi NextCODE’s plan to add a ma­jor Eu­ro­pean se­quenc­ing ini­tia­tive and hub-build­ing project to their glob­al net­work.

The tech out­fit is mak­ing 3-year-old Ge­nomics Med­i­cine Ire­land a sub­sidiary, with fi­nan­cial back­ing tot­ting up to $400 mil­lion to see through an ef­fort to se­quence the genomes of 400,000 res­i­dents in Ire­land — about 10% of the pop­u­la­tion — in search of in­sights in­to the way spe­cif­ic genes in­flu­ence dis­ease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER